Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (168)

View All

Latest Posts

About This Stock More About This Stock
E How Will JNJ's Stock Move After Earnings?
Article By: WhisperNumber
Monday, January 21, 2019 6:38 PM EST
Johnson & Johnson is expected to report earnings tomorrow before market open. The whisper number is $1.95, in-line with the analysts' estimates and showing neutral confidence from the WhisperNumber community.
In this article: JNJ
Read
The Impact Of Dividend Increases Through December Of 2018
Article By: Dividend Diplomats
Sunday, January 13, 2019 1:16 AM EST
Given another quarter-end had recently passed, I wanted to reflect on what occurred over the last full-year. Specifically dividend increases and their impact.
In this article: CAT, DE, EMR, FE, JNJ, KMI, MCD, NSC, PM, ROK
Read
J&J Slides After Failing To Overturn $4.7 Billion Talc Verdict
Article By: Tyler Durden
Wednesday, December 19, 2018 1:41 PM EST
It's been a tough week for Johnson & Johnson, and it just got worse.
In this article: JNJ
Read
Johnson & Johnson Stock Not Discounted Much After Renewed Talc Media Blitz
Article By: Chad Brand
Tuesday, December 18, 2018 11:43 AM EST
Whenever news like this hits, especially with large dominant franchises with plenty of free cash flow to cover possible legal verdicts, it pays to see if investors are getting a short-term bargain.
In this article: JNJ
Read
J&J $40B Loss In Market Cap On Talc Report 'Seems Excessive,' Says Wells Fargo
Article By: The Fly
Sunday, December 16, 2018 3:22 PM EST
Wells Fargo analyst Lawrence Biegelsen believes Johnson & Johnson shares have been oversold based on today's Reuters article suggesting that the company knew about asbestos in its baby powder for decades but never told the FDA.
In this article: JNJ
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!

$JNJ

Comments Status Updates
Johnson & Johnson: Recession Safety, Growth And Valuation
Stuart Saunders • 10/1/2018 2:44:49 AM

Inventors, do not trust johnson and Johnson $JNJ

Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Bill Myers • 7/12/2018 12:37:26 PM

Still not impressed with $JNJ.

1 to 2 of 2 comments